The growth attainment, hematological, iron status and inflammatory profile of Guatemalan juvenile end-stage renal disease patients

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  De Almeida, Juliana Casimiro ^a,b   Lou Meda, Randall ^c   Olbert, Marion ^b   Seifert, Markus ^d   Weiss, Günter ^d   Wiegerinck, Erwin T ^e   Swinkels, Dorine W ^e   Solomons, Noel W ^a   Schümann, Klaus ^f  

^a Center for Studies of Sensory Impairment Aging and Metabolism Guatemala   (Guatemala)

^b MBR Optical Systems   (Germany)

^c Roosevelt Hospital   (Guatemala)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; IRON SACCHARATE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; HEPCIDIN 25, HUMAN;

ADOLESCENT; ADULT; ANEMIA; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; END STAGE RENAL DISEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GROWTH RATE; GUATEMALAN; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; ION EXCHANGE CHROMATOGRAPHY; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; LEUKOCYTE COUNT; MALE; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN METABOLISM; STUNTING; TIME OF FLIGHT MASS SPECTROMETRY; BLOOD; CLINICAL TRIAL; COMPLICATION; GUATEMALA; KIDNEY FAILURE, CHRONIC; MORPHOMETRY; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA; BODY WEIGHTS AND MEASURES; CHILD; FEMALE; FERRITINS; GUATEMALA; HEPCIDINS; HUMANS; INFLAMMATION; IRON; KIDNEY FAILURE, CHRONIC; MALE; YOUNG ADULT;

EID: 84948656684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140062     Document Type: Article

References (82)

1. World Bank. Guatemala Overview; 2015. Available: http://www.worldbank.org/en/country/guatemala/overview. Accessed 23 June 2015.
2. United Nations Development Programme. Global Launch of 2014 Human Development Report; 2014. Available: http://hdr.undp.org/en/2014-report. Accessed 9 July 2015.
3. World Bank. Guatemala Poverty Assessment; 2009. Available: http://siteresources.worldbank.org/INTLACREGTOPPOVANA/Resources/GuatemalaPovertyAssessmentEnglish.pdf. Accessed 24 June 2015.
4. United Nations Children's Fund (UNICEF). Tracking progress on child and maternal nutrition. A survival and development priority. New York: UNICEF; 2009.
5. World Bank. Nutrition at a glance: Guatemala; 2010. Available: http://siteresources.worldbank.org/INTLACREGTOPNUT/Resources/Guatemala4-20-10.pdf.
6. Mata L. Diarrheal disease as a cause of malnutrition. Am. J. Trop. Med. Hyg. 1992;47:16-27. PMID: 1632472
7. Solomons NW. Pathways to the impairment of human nutritional status by gastrointestinal pathogens. Parasitology. 1993;107 Suppl: S19-35. PMID: 8115184
8. Cook DM, Swanson RC, Eggett DL, Booth GM. A retrospective analysis of prevalence of gastrointestinal parasites among school children in the Palajunoj Valley of Guatemala. J Health Popul Nutr. 2009;27:31-40. PMID: 19248646
9. Jensen LA, Marlin JW, Dyck DD, Laubach HE. Prevalence of multi-gastrointestinal infections with helminth, protozoan and Campylobacter spp. in Guatemalan children. J Infect Dev Ctries. 2009;3:229-234. PMID: 19759480
10. Duffy T, Montenegro-Bethancourt G, Solomons NW, Belosevic M, Clandinin MT. Prevalence of giardiasis in children attending semi-urban daycare centres in Guatemala and comparison of 3 giardia detection tests. J Health Popul Nutr. 2013;31:290-293. PMID: 23930348
11. Boy E, Bruce N, Delgado H. Birth weight and exposure to kitchen wood smoke during pregnancy in rural Guatemala. Environ. Health Perspect. 2002;110:109-114. PMID: 11781172
12. Neufeld LM, Haas JD, Ruel MT, Grajeda R, Naeher LP. Smoky indoor cooking fires are associated with elevated hemoglobin concentration in iron-deficient women. Rev. Panam. Salud Publica. 2004;15:110-118. PMID: 15030656
13. Montenegro-Bethancourt G, Vossenaar M, Doak CM, Solomons NW. Total daily water intake in Guatemalan children. Food Nutr Bull. 2009;30:340-350. PMID: 20496624
14. Vásquez WF. Municipal water services in Guatemala. Exploring official perceptions. Water Policy. 2011;13:362.
15. Al-Saedy A J H, Al-Kahichy H R A. The current status of hemodialysis in Baghdad. Saudi J Kidney Dis Transpl. 2011;22:362-367. PMID: 21422648
16. Najafi I, Alatab S, Atabak S, Majelan NN, Sanadgol H, Makhdoomi K, et al. Seventeen years' experience of peritoneal dialysis in Iran: first official report of the Iranian peritoneal dialysis registry. Perit Dial Int. 2014;34:636-642. doi: 10.3747/pdi.2012.00054 PMID: 23733658
17. Bisigniano L, López-Rivera A, Tagliafichi V, Fernández VJ, Soratti CA. Analysis of mortality while on waiting list for kidney transplant in adults in Argentina 2005-2009. Transplant. Proc. 2012;44:2239-2241. doi: 10.1016/j.transproceed.2012.07.128 PMID: 22974963
18. Divino-Filho JC, de Andrade Bastos K, Qureshi AR, Riella MC, Pecoits-Filho R, Fernandes N. Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): from conception to execution of a national peritoneal dialysis reality check. Contrib Nephrol. 2012;178:23-29. doi: 10.1159/000337793 PMID: 22652711
19. Alashek WA, McIntyre CW, Taal MW. Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya. BMC Nephrol. 2012;13:33. doi: 10.1186/1471-2369-13-33 PMID: 22682181
20. Okunola O, Akinsola A, Ayodele O. Kidney diseases in Africa: aetiological considerations, peculiarities and burden. Afr J Med Med Sci. 2012;41:119-133. PMID: 23185909
21. Goraya N, Wesson DE. Dietary management of chronic kidney disease: protein restriction and beyond. Curr. Opin. Nephrol. Hypertens. 2012;21:635-640. doi: 10.1097/MNH.0b013e328357a69b PMID: 23079747
22. Furth SL, Alexander DC, Neu AM, Hwang W, Powe NR, Fivush BA. Does growth retardation indicate suboptimal clinical care in children with chronic renal disease and those undergoing dialysis. Semin. Nephrol. 2001;21:463-469. PMID: 11559887
23. Fischbach M, Fothergill H, Seuge L, Zaloszyc A. Dialysis strategies to improve growth in children with chronic kidney disease. J Ren Nutr. 2011;21:43-46. doi: 10.1053/j.jrn. 2010.10.022 PMID: 21195918
24. Vogt BA, Avner EB. Acute renal failure. 17th ed. Philadelphia: Nelson Text Book of Pediatrics. Chapter 527, pp 1767-1775;2004.
25. Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr. Nephrol. 2010;25:1699-1706. doi: 10.1007/s00467-010-1538-6 PMID: 20464428
26. Weiss G, Goodnough LT. Anemia of chronic disease. N. Engl. J. Med. 2005;352:1011-1023. PMID: 15758012
27. Rao M, Guo D, Perianayagam MC, Tighiouart H, Jaber BL, Pereira B J G, et al. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis. 2005;45:324-333. PMID: 15685511
28. Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int. 2004;65:1449-1460. PMID: 15086488
29. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link. Kidney Int. 2001;59:407-414. PMID: 11168922
30. Goldstein SL, Leung JC, Silverstein DM. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Clin J Am Soc Nephrol. 2006;1:979-986. PMID: 17699316
31. Cerón A, Fort MP, Morine CM, Lou-Meda R. Chronic kidney disease among children in Guatemala. Rev. Panam. Salud Publica. 2014;36:376-382. PMID: 25711748
32. Lou-Meda R. Comprehensive approach to pediatric kidney diseases in Guatemala. Clin. Nephrol. 2015;83:82-84. PMID: 25725248
33. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-forage, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization (312 pages); 2006.
34. Dirren H, Logman MH, Barclay DV, Freire WB. Altitude correction for hemoglobin. Eur J Clin Nutr. 1994;48:625-632. PMID: 8001519
35. World Health Organization. WHO Global Infobase; 2011. Available: https://apps.who.int/infobase/report.aspx.
36. Kroot J J C, Laarakkers C M M, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin. Chem. 2010;56:1570-1579. doi: 10.1373/clinchem.2010.149187 PMID: 20739637
37. Laarakkers C M M, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, et al. Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform. PLoS ONE. 2013;8:e75518. doi: 10.1371/journal.pone.0075518 PMID: 24124495
38. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011;117:e218-25. doi: 10.1182/blood-2011-02-337907 PMID: 21527524
39. Martorell R, Young MF. Patterns of stunting and wasting: potential explanatory factors. Adv Nutr. 2012;3:227-233. doi: 10.3945/an. 111.001107 PMID: 22516733
40. Gluckman PD, Hanson MA, Buklijas T. A conceptual framework for the developmental origins of health and disease. J Dev Orig Health Dis. 2010;1:6-18. doi: 10.1017/S2040174409990171 PMID: 25142928
41. Drake AJ, Liu L. Intergenerational transmission of programmed effects: public health consequences. Trends Endocrinol. Metab. 2010;21:206-213. doi: 10.1016/j.tem.2009.11.006 PMID: 20005734
42. Morgan DK, Whitelaw E. The case for transgenerational epigenetic inheritance in humans. Mamm. Genome. 2008;19:394-397. doi: 10.1007/s00335-008-9124-y PMID: 18663528
43. Martorell R, Zongrone A. Intergenerational influences on child growth and undernutrition. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:302-314. doi: 10.1111/j.1365-3016.2012.01298.x PMID: 22742617
44. Victora CG, de Onis M, Hallal PC, Blössner M, Shrimpton R. Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics. 2010;125:e473-80. doi: 10.1542/peds.2009-1519 PMID: 20156903
45. Corvalán C, Gregory CO, Ramirez-Zea M, Martorell R, Stein AD. Size at birth, infant, early and later childhood growth and adult body composition: a prospective study in a stunted population. Int J Epidemiol. 2007;36:550-557. PMID: 17376801
46. Martorell R, Melgar P, Maluccio JA, Stein AD, Rivera JA. The nutrition intervention improved adult human capital and economic productivity. J. Nutr. 2010;140:411-414. doi: 10.3945/jn. 109.114504 PMID: 20032473
47. Bogin B, Smith P, Orden AB, Varela Silva MI, Loucky J. Rapid change in height and body proportions of Maya American children. Am. J. Hum. Biol. 2002;14:753-761. PMID: 12400036
48. Nissel R, Lindberg A, Mehls O, Haffner D. Factors predicting the near-final height in growth hormonetreated children and adolescents with chronic kidney disease. J. Clin. Endocrinol. Metab. 2008;93:1359-1365. doi: 10.1210/jc.2007-2302 PMID: 18198222
49. Sozeri B, Mir S, Kara OD, Dincel N. Growth impairment and nutritional status in children with chronic kidney disease. Iran J Pediatr. 2011;21:271-277. PMID: 23056801
50. Kuhlmann MK, Levin NW. Interaction between nutrition and inflammation in hemodialysis patients. Contrib Nephrol. 2005;149:200-207. PMID: 15876844
51. Lerner GR, Warady BA, Sullivan EK, Alexander SR. Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr. Nephrol. 1999;13:404-417. PMID: 10412861
52. Nissel R, Brázda I, Feneberg R, Wigger M, Greiner C, Querfeld U, et al. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int. 2004;66:792-800. PMID: 15253735
53. Stickler GB. Growth failure in renal disease. Pediatr. Clin. North Am. 1976;23:885-894. PMID: 792785
54. Ehrich JH, Rizzoni G, Brunner FP, Brynger H, Geerlings W, Fassbinder W, et al. Combined report on regular dialysis and transplantation of children in Europe, 1989. Nephrol. Dial. Transplant. 1991;6 Suppl 1:37-47. PMID: 2038431
55. Bacchetta J, Ranchin B, Demède D, Allard L. The consequences of pediatric renal transplantation on bone metabolism and growth. Curr Opin Organ Transplant. 2013;18:555-562. doi: 10.1097/MOT. 0b013e3283651b21 PMID: 23995376
56. Stefanidis CJ, Klaus G. Growth of prepubertal children on dialysis. Pediatr Nephrol. 2007;22:1251-1259. PMID: 17401584
57. FAO. Nutrition Country Profiles: Guatemala; 2010. Available: http://www.fao.org/ag/agn/nutrition/profiles-en. stm. Accessed 8 October 2011.
58. Allen LH, Rosado JL, Casterline JE, López P, Muñoz E, Garcia OP, et al. Lack of hemoglobin response to iron supplementation in anemic mexican preschoolers with multiple micronutrient deficiencies. Am. J. Clin. Nutr. 2000;71:1485-1494. PMID: 10837289
59. Schümann K, Romero-Abal ME, Mäurer A, Luck T, Beard J, Murray-Kolb L, et al. Haematological response to haem iron or ferrous sulphate mixed with refried black beans in moderately anaemic Guatemalan pre-school children. Public Health Nutr. 2005;8:572-581. PMID: 16236186
60. Hallberg L. Wheat fiber, phytates and iron absorption. Scand. J. Gastroenterol. Suppl. 1987;129:73-79. PMID: 2820048
61. Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood. 2006;108:1381-1387. PMID: 16621968
62. Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, et al. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur. J. Clin. Invest. 2009;39:883-890. doi: 10.1111/j.1365-2362.2009.02182.x PMID: 19563467
63. Zaritsky J, Young B, Gales B, Wang H, Rastogi A, Westerman M, et al. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol. 2010;5:1010-1014. doi: 10.2215/CJN.08161109 PMID: 20299375
64. Peters H P E, Laarakkers C M M, Swinkels DW, Wetzels J F M. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol. Dial. Transplant. 2010;25:848-853. doi: 10.1093/ndt/gfp546 PMID: 19854845
65. Kuragano T, Shimonaka Y, Kida A, Furuta M, Nanami M, Otaki Y, et al. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. Am. J. Nephrol. 2010;31:534-540. doi: 10.1159/000312381 PMID: 20484891
66. Swinkels DW, Wetzels J F M. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease. Nephrol. Dial. Transplant. 2008;23:2450-2453. doi: 10.1093/ndt/gfn267 PMID: 18495744
67. Kroot J J C, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin. Chem. 2011;57:1650-1669. doi: 10.1373/clinchem.2009.140053 PMID: 21989113
68. Dallalio G, Law E, Means RT. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood. 2006;107:2702-2704. PMID: 16332970
69. Huang Z, Gao D, Letteri JJ, Clark WR. Blood-membrane interactions during dialysis. Semin Dial. 2009;22:623-628. doi: 10.1111/j.1525-139X.2009.00658.x PMID: 20017832
70. Nakatan T, Takemoto Y, Tsuchida AK. The effect of vitamin E-bonded dialyzer membrane on red blood cell survival in hemodialyzed patients. Artif Organs. 2003;27:214-217. PMID: 12662204
71. Singh AK, Coyne DW, Shapiro W, Rizkala AR. Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation. Kidney Int. 2007;71:1163-1171. PMID: 17396118
72. Koizumi M, Komaba H, Fukagawa M. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Contrib Nephrol. 2013;180:110-123. doi: 10.1159/000346791 PMID: 23652554
73. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents-time for a reevaluation. N. Engl. J. Med. 2010;362:189-192. doi: 10.1056/NEJMp0912328 PMID: 20054037
74. Kroot J J C, van Herwaarden AE, Tjalsma H, Jansen R T P, Hendriks J C M, Swinkels DW. Second round robin for plasma hepcidin methods: first steps toward harmonization. Am. J. Hematol. 2012;87:977-983. doi: 10.1002/ajh.23289 PMID: 22886770
75. Atkinson MA, White CT. Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist. Pediatr. Nephrol. 2012;27:33-40. doi: 10.1007/s00467-011-1832-y PMID: 21400189
76. Zaritsky J, Young B, Wang H, Westerman M, Olbina G, Nemeth E, et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1051-1056. doi: 10.2215/CJN.05931108 PMID: 19406957
77. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010;142:24-38. doi: 10.1016/j.cell.2010.06.028 PMID: 20603012
78. Rostoker G, Griuncelli M, Loridon C, Couprie R, Benmaadi A, Bounhiol C, et al. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. Am. J. Med. 2012;125:991-999-e1. doi: 10.1016/j.amjmed.2012.01.015 PMID: 22998881
79. Ghoti H, Rachmilewitz EA, Simon-Lopez R, Gaber R, Katzir Z, Konen E, et al. Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. Eur. J. Haematol. 2012;89:87-93. doi: 10.1111/j.1600-0609.2012.01783.x PMID: 22435497
80. de Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J. Clin. Invest. 1997;99:643-650. PMID: 9045866
81. Kruger HS, Pretorius R, Schutte AE. Stunting, adiposity, and low-grade inflammation in African adolescents from a township high school. Nutrition. 2010;26:90-99. doi: 10.1016/j.nut.2009.10.004 PMID: 20005466
82. Golden MH. The nature of nutritional deficiency in relation to growth failure and poverty. Acta Paediatr Scand Suppl. 1991;374:95-110. PMID: 1957635